Vendas Alterar Data
AstraZeneca USD 15.38B 90M 2026-06
Genmab DKK 1.16B 259M 2026-06
GlaxoSmithKline GBP 8.41B 781M 2026-06
GRIFOLS EUR 1.87B 170M 2026-06
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Lakefront Biotherapeutics EUR 12.11M 5.61M 2026-06
Qiagen NV USD 463.12M 43.9M 2026-06
UCB EUR 4.25B 764M 2025-12